trifluoperazine has been researched along with Atherosclerotic Parkinsonism in 20 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dysphagia is a potentially life-threatening complication of drug-induced parkinsonism." | 1.29 | Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. ( Bashford, G; Bradd, P, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (90.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sadananda, SK | 1 |
| Holla, B | 1 |
| Viswanath, B | 1 |
| Narasimha, A | 1 |
| Sebastian, A | 1 |
| Math, SB | 1 |
| Chandrashekar, CR | 1 |
| Sheppard, C | 1 |
| Merlis, S | 1 |
| Keshavan, MS | 1 |
| Narashimha Rao, IV | 1 |
| Narayanan, HS | 1 |
| Bashford, G | 1 |
| Bradd, P | 1 |
| Sahoo, RN | 1 |
| Mitra, GC | 1 |
| Mohanty, PC | 1 |
| Stokes, HB | 1 |
| Martin, IC | 1 |
| Crowley, TJ | 3 |
| Hoehn, MM | 3 |
| Rutledge, CO | 3 |
| Stallings, MA | 2 |
| Heaton, RK | 1 |
| Sundell, S | 2 |
| Stilson, D | 1 |
| Srikant, G | 1 |
| Kantharaj, L | 1 |
| Rao, PR | 1 |
| Van Woert, MH | 2 |
| Sethy, VH | 1 |
| Ambani, LM | 2 |
| Bordeleau, JM | 1 |
| Tétreault, L | 1 |
| Morrison, AB | 1 |
| Webster, RA | 1 |
| Bowers, MB | 1 |
| Demars, JP | 1 |
| Zolotnitskii, RI | 1 |
| Kutsenok, BM | 1 |
| Gastev, MD | 1 |
| Ridges, AP | 1 |
| Harper, P | 1 |
| Fischer, R | 1 |
| Knopp, W | 1 |
| Griffin, F | 1 |
| Ekdawi, MY | 1 |
| Fowke, R | 1 |
2 trials available for trifluoperazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparat | 1975 |
Neuromuscular effects of long-term phenothiazine medication, electroconvulsive therapy and leucotomy.
Topics: Aged; Chlorpromazine; Clinical Trials as Topic; Electric Stimulation Therapy; Female; Haloperidol; H | 1966 |
18 other studies available for trifluoperazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Humans; Male; Middle Aged | 2013 |
Drug-induced extrapyramidal symptoms: their incidence and treatment.
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasymp | 1967 |
Rate of blinking may predict neuroleptic-induced parkinsonism.
Topics: Blinking; Humans; Parkinson Disease, Secondary; Trifluoperazine | 1983 |
Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report.
Topics: Aged; Deglutition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administrat | 1996 |
Irreversible drug induced parkinsonism (two case reports).
Topics: Adult; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Phenothiazines; Prochlorperazine; Tr | 1975 |
Trifluoroperazine for the symptomatic treatment of chorea.
Topics: Acute Disease; Adolescent; Adult; Cerebrovascular Disorders; Child; Chorea; Drug Evaluation; Female; | 1975 |
Dopamine excretion and vulnerability to drug-induced Parkinsonism. Schizophrenic patients.
Topics: Adult; Dopamine; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary | 1978 |
The Parkinsonian syndrome and its dopamine correlates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dopamine; Extrapyramidal Tracts; Female; Homovanillic A | 1977 |
Low urinary dopamine and prediction of phenothiazine-induced Parkinsonism: a preliminary report.
Topics: Adult; Dopamine; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease, Secondary; | 1976 |
Two cases of parkinsonism developing after industrial exposure to trifluperazine.
Topics: Adult; Humans; Male; Occupational Diseases; Parkinson Disease, Secondary; Trifluoperazine | 1986 |
Effect of phenothiazines on central cholinergic activity.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Brain Chemistry; Chlorp | 1974 |
[Study of extrapyramidal manifestations induced by neuroleptics].
Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperid | 1972 |
Drug-induced experimental Parkinsonism.
Topics: Animals; Atropine; Benztropine; Butyrophenones; Cats; Chlorpromazine; Dose-Response Relationship, Dr | 1973 |
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; H | 1973 |
[On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Catatonia; Chlorpromazine; Cognition Disorders; Hall | 1969 |
Pink spot--is it a drug artefact?
Topics: Amitriptyline; Amobarbital; Chlorpromazine; Chromatography; Haloperidol; Humans; Mental Disorders; P | 1970 |
Taste sensitivity and the appearance of phenothiazine-tranquilizer induced extrapyramidal symptoms.
Topics: Extrapyramidal Tracts; Female; Humans; Movement Disorders; Parkinson Disease, Secondary; Phenothiazi | 1965 |
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Parasympatholytic | 1966 |